European Respiratory Review
Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis
Manuela Platé, Delphine Guillotin, Rachel C Chambers
Eur Respir Rev, 29 (157) 200269; 10.1183/16000617.0269-2020
Interstitial lung diseases
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Manuela Platé, Delphine Guillotin, Rachel C Chambers. The promise of mTOR as a therapeutic target pathway in idiopathic pulmonary fibrosis. Eur Respir Rev, 29 (157) 200269; 10.1183/16000617.0269-2020
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Quality Improvement in a Sleep Clinic: To increase the capacity and reduce the time to treatment for patients with Obstructive Sleep Apnoea
Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients